Recent advances in genetic predisposition to clinical acute lung injury
- PMID: 19218355
- PMCID: PMC2681344
- DOI: 10.1152/ajplung.90269.2008
Recent advances in genetic predisposition to clinical acute lung injury
Abstract
It has been well established that acute lung injury (ALI), and the more severe presentation of acute respiratory distress syndrome (ARDS), constitute complex traits characterized by a multigenic and multifactorial etiology. Identification and validation of genetic variants contributing to disease susceptibility and severity has been hampered by the profound heterogeneity of the clinical phenotype and the role of environmental factors, which includes treatment, on outcome. The critical nature of ALI and ARDS, compounded by the impact of phenotypic heterogeneity, has rendered the amassing of sufficiently powered studies especially challenging. Nevertheless, progress has been made in the identification of genetic variants in select candidate genes, which has enhanced our understanding of the specific pathways involved in disease manifestation. Identification of novel candidate genes for which genetic association studies have confirmed a role in disease has been greatly aided by the powerful tool of high-throughput expression profiling. This article will review these studies to date, summarizing candidate genes associated with ALI and ARDS, acknowledging those that have been replicated in independent populations, with a special focus on the specific pathways for which candidate genes identified so far can be clustered.
Figures
Comment in
-
Gene association studies in acute lung injury: replication and future direction.Am J Physiol Lung Cell Mol Physiol. 2009 May;296(5):L711-2. doi: 10.1152/ajplung.00080.2009. Epub 2009 Mar 13. Am J Physiol Lung Cell Mol Physiol. 2009. PMID: 19286930 Free PMC article. No abstract available.
References
-
- The International HapMap Project. Nature 426: 789–796, 2003. - PubMed
-
- Adamzik M, Frey U, Sixt S, Knemeyer L, Beiderlinden M, Peters J, Siffert W. ACE I/D but not AGT (−6)A/G polymorphism is a risk factor for mortality in ARDS. Eur Respir J 29: 482–488, 2007. - PubMed
-
- Adamzik M, Frey UH, Rieman K, Sixt S, Beiderlinden M, Siffert W, Peters J. Insertion/deletion polymorphism in the promoter of NFKB1 influences severity but not mortality of acute respiratory distress syndrome. Intensive Care Med 33: 1199–1203, 2007. - PubMed
-
- Adamzik M, Frey UH, Riemann K, Sixt S, Lehmann N, Siffert W, Peters J. Factor V Leiden mutation is associated with improved 30-day survival in patients with acute respiratory distress syndrome. Crit Care Med 36: 1776–1779, 2008. - PubMed
-
- Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 186: 1522–1525, 2002. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
